This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Cytohesins, ARF GTPases and Neurodegeneration Investments > €500k United States of America Motor neurone diseases 2016
Developing, evaluating, and disseminating new methods and technologies to advance Parkinson disease research Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016
Novel mechanisms of actin dynamics underlying cell motility, axon growth, and ALS Investments > €500k United States of America Motor neurone diseases 2016
Enhanced respiratory plasticity in models of respiratory motor neuron death Investments > €500k United States of America Motor neurone diseases 2016
Toxicant-induced synaptic dysfunction and neurotoxicity in Parkinson disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016
Optimization of a novel series of thiazolopyridines for the treatment of SMA Investments > €500k United States of America Spinal muscular atrophy (SMA) 2016
TDP-43 acetylation as a pathogenic modification in ALS & related proteinopathies Investments > €500k United States of America Motor neurone diseases 2016
High Throughput Screening to Discover Chemical Probes and Pharmacological Agents for Modulating Parkin Activity Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016
Molecular Mechanism of LRRK2 Biology and Pathology in Parkinsons Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016
C9orf72 hexanucleotide repeat expansion caused neurodegeneration in ALS and FTD Investments > €500k United States of America Motor neurone diseases 2016
